Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $203.91B.
ENTERPRISE VALUE (EV)
$203.91B
Novo Nordisk A/S
Market Cap
$188.86B
Enterprise Value (EV)
$203.91B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Novo Nordisk A/S (NVO) | $188.86B | $203.91B |
| Gilead Sciences, Inc. (GILD)vs › | $181.64B | $204.71B |
| Abbott Laboratories (ABT)vs › | $176.59B | $204.09B |
| Amgen Inc. (AMGN)vs › | $202.74B | $246.06B |
| Pfizer Inc. (PFE)vs › | $157.02B | $219.24B |
| Danaher Corporation (DHR)vs › | $147.13B | $169.34B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $238.35B | $276.84B |
| Intuitive Surgical, Inc. (ISRG)vs › | $133.24B | $130.48B |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.62B | $126.45B |
| Bristol-Myers Squibb Company (BMY)vs › | $130.18B | $164.58B |
Market Cap
$188.86B
Total Debt
$19.20B
Cash
$4.15B
Enterprise Value
$203.91B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
